(Q40931600)

25 September 2017

Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

1 reference

M. K. Samson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

L. H. Baker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

R. W. Talley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

R. J. Fraile

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

B. McDonald

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356980

6 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=356980

6 April 2023

publication date

1 August 1978

1 reference

25 September 2017

Cancer Treatment Reports

1 reference

25 September 2017

62

1 reference

25 September 2017

8

1 reference

25 September 2017

1223-1225

1 reference

25 September 2017

Identifiers

1 reference